Delegates at C21 Bioventures had the opportunity to hear keynote addresses from Mr. Michael Gaito, Managing Director at J.P. Morgan, and Dr. George Scangos, Chief Executive Officer at Biogen Idec, Inc., both offering unique perspectives and expert insight into current issues affecting the biotechnology industry. The keynote addresses along with leadership sessions at C21 BioVentures echoed a clear need for capital efficiency, innovative business models and creative partnerships across the industry.
As 2011 progresses there are both new opportunities and new challenges for biotech companies, pharmaceutical partners and investors. C21 BioVentures provides a platform to network with your peers, learn from new business models and pre-schedule face-to-face meetings with the partners and investors you need to succeed.
C21 BioVentures 2012 will be held in Napa, California at the Meritage Resort from May 22-24, 2012.
Technology Vision Group is a life science networking company that is built on industry expertise and long-standing relationships. We provide our clients with the connections, the venues, and the access they need to succeed in a global life science world. http://www.techvision.com
» See All: Pharmaceuticals/Drug Discovery Conferences